BGLC · BioNexus Gene Lab Corp · Analyst Estimates
$1.21
-0.02 (-1.86%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing states the doubt was alleviated.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued. Management believes that the Company’s existing cash balance, together with its positive working capital position, will provide sufficient liquidity to fund operations and meet its obligations as they become due for at least the next twelve months from the date these condensed consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.53M
Shares
2.93M
Volume · Oct 20
1043
Avg daily vol (3M)
11.4K
Analyst Estimates
Compare analyst forecasts for BioNexus Gene Lab Corp across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Published by the company
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.
No published consensus found
No analyst consensus was found on the examined investor-relations pages. Coverage is not market-wide.